The product monograph for Doribax will be updated to reflect findings from a study showing a higher mortality rate and a lower cure rate among patients taking Doribax 1g every 8 hours in a fixed 7-day course as compared to those taking a fixed 10-day course of imipenem-cilastatin.

La monographie de Doribax sera mise à jour pour tenir compte des résultats d’une étude clinique démontrant un taux de mortalité plus élevé et de guérison plus faible chez les patients traités avec le Doribax, 1g toutes les 8 heures pendant 7 jours, en comparaison à un traitement fixe de 10 jours avec imipénem-cilastatine.

Janssen Inc., in consultation with Health Canada, would like to alert you to the risk of fatal outcome associated with the inadvertent intrathecal administration of the antineoplastic drug VELCADE® (bortezomib).

Janssen Inc, en consultation avec Santé Canada, aimerait vous alerter du risque d'issue fatale associé à l'administration involontaire par voie intrathécale de l'antinéoplasique VELCADE® (bortézomib).

Maximum doses for the antidepressant Celexa (citalopram) have been decreased and the product monograph has been updated accordingly given new cardiac safety data showing an increased risk of QT prolongation and abnormal heart rhythms at high doses.

Maximum doses for the antidepressant Celexa (citalopram) have been decreased and the product monograph has been updated accordingly given new cardiac safety data showing an increased risk of QT prolongation and abnormal heart rhythms at high doses.

La dose maximale de l'antidépresseur Celexa (citalopram) a été réduite. La monographie du produit a été mise à jour basé sur de nouvelles données d'innocuité cardiaque démontrant un risque accru de prolongement de l'intervalle QT et de rhythmes cardiaques anormaux à doses élevées.

A listing of drugs pursuant to sub-section C.08.004.1(9) of the Food and Drug Regulations.

Une liste des drogues en vertu de paragraphe C.08.004.1(9) du èglement sur les aliments et drogues.

Covidien is conducting a voluntary recall of all production lots for the Duet TRS Universal Straight and Articulating Single Use Loading Units (SULU) with respect to the use of this product family in the thoracic cavity. Serious injuries and deaths have occurred due to the failure mode associated with this recall.

Covidien procède à un rappel volontaire de tous les lots de production de chargeurs universels à usage unique (SULU) Duet TRS droits et articulés destinés à être utilisés dans une cavité thoracique. Des blessures graves et des décès sont survenus en raison du type de défaillance associé à ce rappel.

17 weight loss products; Uprizing 2.0; Get Stiff, Maxi Mize; Ying Da Wang tablets; Slimina weightloss capsules, S-shape slim capsules; Athri-Eze, Sear Heang Tienchi Tu Chung Wan, Wiku Jahe Kencur (Akur Mujarab), Cap Wijaya Kusuma (An Ki It); Cardiotium, Paidusu, SlimEasy Herbs Capsule, Tianran Zuanshi Xianweisu; [LuShenPai] Specific Hou Ton Qing, [AA] Pe Min Kan Wan / 17 weight loss products; Uprizing 2.0; Get Stiff, Maxi Mize; Ying Da Wang tablets; Slimina weightloss capsules, S-shape slim capsules; Athri-Eze, Sear Heang Tienchi Tu Chung Wan, Wiku Jahe Kencur (Akur Mujarab), Cap Wijaya Kusuma (An Ki It); Cardiotium, Paidusu, SlimEasy Herbs Capsule, Tianran Zuanshi Xianweisu; [LuShenPai] Specific Hou Ton Qing, [AA] Pe Min Kan Wan

Interim study results indicate that there is an increased risk of non-fatal stroke, renal complications (end stage renal disease and renal death), hyperkalemia and hypotension in diabetic patients treated with aliskiren. The combination of aliskiren with ACE inhibitors and ARBs is now contraindicated in patients with type 2 diabetes. The Product Monograph will be updated accordingly.

Interim study results indicate that there is an increased risk of non-fatal stroke, renal complications (end stage renal disease and renal death), hyperkalemia and hypotension in diabetic patients treated with aliskiren. The combination of aliskiren with ACE inhibitors and ARBs is now contraindicated in patients with type 2 diabetes. The Product Monograph will be updated accordingly.

Les résultats préliminaires d'une étude indiquent un risque accru d'accident vasculaire cérébral (AVC) non-mortel, de complications rénales (maladie rénale terminale ou décès d'origine rénal), d'hyperkaliémie et d'hypotension chez les patients diabétiques traités par de l'aliskirène. Le traitement avec de l'aliskirène combiné à un iECA ou un ARA est maintenant contre-indiqué chez les patients atteints diabète de type 2. La monographie de produit sera modifiée selon cette information.

Further to previous communications, Health Canada is advising Canadians that we have identified two additional Male and Female Harmony retail stores that were selling unauthorized health products. These products have been removed from sale. It is important to note that the Male and Female Harmony store located at 4554 Kingsway, Burnaby, B.C. is also known as "Love in Love Adult Store."

Health Canada is informing Canadians that our review of Champix is now complete and the label has been updated with new information with respect to cardiovascular safety. Champix (the brand name for varenicline tartrate) is a prescription drug used to help patients quit smoking in combination with supportive counselling.

Health Canada is informing Canadians that our review of Champix is now complete and the label has been updated with new information with respect to cardiovascular safety. Champix (the brand name for varenicline tartrate) is a prescription drug used to help patients quit smoking in combination with supportive counselling.

Advisories and Recalls for the Public - MedEffect Canada

Santé Canada informe les Canadiens qu'il a maintenant terminé l'examen de Champix et mis à jour l'étiquette afin de tenir compte des risques cardiovasculaires. Champix (nom de marque du tartrate de varénicline) est un médicament d'ordonnance utilisé pour aider les patients à cesser de fumer dans le cadre d'un programme de soutien.